These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20556340)

  • 21. [Hypertension as a function of age].
    Gensini GF; Corradi F
    Ital Heart J; 2000 Jun; 1 Suppl 2():23-31. PubMed ID: 10905125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Target values in hypertension treatment. Will they apply in older patients with hypertension, diabetics and in patients with IHD?].
    Widimský J
    Vnitr Lek; 2009 Sep; 55(9):833-40. PubMed ID: 19785385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertension and the eye: changing perspectives.
    Chatterjee S; Chattopadhyay S; Hope-Ross M; Lip PL
    J Hum Hypertens; 2002 Oct; 16(10):667-75. PubMed ID: 12420190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Independent association of circulating resistin with glomerular filtration rate in the early stages of essential hypertension.
    Dimitriadis K; Tsioufis C; Selima M; Tsiachris D; Miliou A; Kasiakogias A; Andrikou E; Tousoulis D; Stefanadis C
    J Hum Hypertens; 2009 Oct; 23(10):668-73. PubMed ID: 19262583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Premature atherosclerotic cardiovascular disease and systemic lupus erythematosus from bedside to bench.
    Von Feldt JM
    Bull NYU Hosp Jt Dis; 2008; 66(3):184-7. PubMed ID: 18937629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypertension and arteriosclerosis].
    Pessina AC; Pauletto P; Rossi GP; Valle R
    Ann Ital Med Int; 1992; 7(3 Suppl):112S-118S. PubMed ID: 1363625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic and cardiovascular characteristics of hypertension. Familial aspects.
    Neutel JM; Smith DH
    Cardiol Clin; 1995 Nov; 13(4):539-47. PubMed ID: 8565017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pathophysiology of target organ damage in hypertension.
    Karpha M; Lip GV
    Minerva Cardioangiol; 2006 Aug; 54(4):417-29. PubMed ID: 17016413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathobiological determinants of atherosclerosis in youth risk scores are associated with early and advanced atherosclerosis.
    McMahan CA; Gidding SS; Malcom GT; Tracy RE; Strong JP; McGill HC;
    Pediatrics; 2006 Oct; 118(4):1447-55. PubMed ID: 17015535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [From labile or borderline arterial hypertension to mild hypertension. Current data and practical management].
    Wicker P; Dallocchio M
    Ann Cardiol Angeiol (Paris); 1985 Apr; 34(4 Pt 2):253-8. PubMed ID: 3890679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of vascular risk factors in the hypertensive patient.
    Taylor SH
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():10-6. PubMed ID: 2148191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atherosclerosis profile and microalbuminuria in essential hypertension.
    Calviño J; Calvo C; Romero R; Gude F; Sánchez-Guisande D
    Am J Kidney Dis; 1999 Dec; 34(6):996-1001. PubMed ID: 10585307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolated systolic blood pressure elevation in the elderly: mechanisms, risk, and the need for further studies.
    Amery A; Fagard R; Staessen J; Thijs L; van Hoof R
    J Cardiovasc Pharmacol; 1989; 14 Suppl 10():S14-20. PubMed ID: 2483566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The concept of "preclinical arterial hypertension" - in light of non-invasive, ambulatory blood pressure monitoring].
    Cugini P; Fontana S; Pellegrino AM; Lucia P; Stirati G; Cruciani F; Scibilia G; Pachì A
    Recenti Prog Med; 1998 Nov; 89(11):559-68. PubMed ID: 9844440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physical fitness and the relationship between hypertension and markers of atherothrombosis.
    Jessani S; Lip GY
    Am J Hypertens; 2007 Jun; 20(6):676-7. PubMed ID: 17531927
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypertension and lipids.
    Sznajderman M
    Blood Press Suppl; 1996; 1():14-7. PubMed ID: 9162431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Blood pressure components and target organ damage].
    Schillaci G; Reboldi G; Vaudo G
    Ital Heart J Suppl; 2001 Apr; 2(4):363-8. PubMed ID: 19397008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammation.
    Dawood T; Schlaich MP
    Minerva Cardioangiol; 2009 Dec; 57(6):687-704. PubMed ID: 19942842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained Elevated Blood Pressure Accelerates Atherosclerosis Development in a Preclinical Model of Disease.
    Gonzalez-Guerra A; Roche-Molina M; García-Quintáns N; Sánchez-Ramos C; Martín-Pérez D; Lytvyn M; de Nicolás-Hernández J; Rivera-Torres J; Arroyo DF; Sanz-Rosa D; Bernal JA
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localizing factors in atherosclerosis.
    Pescetelli I; Zimarino M; Ghirarduzzi A; De Caterina R
    J Cardiovasc Med (Hagerstown); 2015 Dec; 16(12):824-30. PubMed ID: 25575274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.